Home / Germany / Bionano Genomics Inc
Bionano Genomics Inc
Short position disclosed on October 13, 2023.
1.67% of the capital sold short
2 disclosing funds
2 disclosures on record
US09075F3055 ISIN code
Evolution of the disclosed total
0%0.5%1%1.5%2%
Oct 2025Jan 2026Apr 2026Jul 2026
August 15, 2023 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Walleye Capital LLC | 0.90% | unchanged | October 13, 2023 | |
| Bronte Capital Management Pty Ltd | 0.77% | unchanged | August 15, 2023 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| October 13, 2023 | Walleye Capital LLC | 0.90% | still open |
| August 15, 2023 | Bronte Capital Management Pty Ltd | 0.77% | still open |
Other companies sold short in Germany
- TUI AG 9.00% of the capital sold short
- AUTO1 Group SE 7.29% of the capital sold short
- HelloFresh SE 7.00% of the capital sold short
- Hugo Boss AG 6.18% of the capital sold short
- Gerresheimer AG 5.98% of the capital sold short
- Cancom SE 5.46% of the capital sold short
- PVA TePla AG 5.30% of the capital sold short
- Zalando SE 5.22% of the capital sold short
- LANXESS Aktiengesellschaft 5.11% of the capital sold short
- Tamboran Resources Corp. 4.96% of the capital sold short
- Kontron AG 4.94% of the capital sold short
- Aeluma, INC. 4.82% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Bionano Genomics Inc, source Bundesanzeiger, data as at October 13, 2023, https://www.quivad.com/action/bionano-genomics-inc